glucokinase activator
- Generic Name
- glucokinase activator
Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Type2 Diabetes Mellitus
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-06-04
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- PegBio Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT03973515
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath